246 related articles for article (PubMed ID: 24717019)
1. Cytological grading of canine cutaneous mast cell tumours.
Scarpa F; Sabattini S; Bettini G
Vet Comp Oncol; 2016 Sep; 14(3):245-51. PubMed ID: 24717019
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
Stefanello D; Buracco P; Sabattini S; Finotello R; Giudice C; Grieco V; Iussich S; Tursi M; Scase T; Di Palma S; Bettini G; Ferrari R; Martano M; Gattino F; Marrington M; Mazzola M; Elisabetta Vasconi M; Annoni M; Marconato L
J Am Vet Med Assoc; 2015 Apr; 246(7):765-9. PubMed ID: 25794126
[TBL] [Abstract][Full Text] [Related]
3. Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens.
Hergt F; von Bomhard W; Kent MS; Hirschberger J
Vet Clin Pathol; 2016 Sep; 45(3):477-83. PubMed ID: 27483044
[TBL] [Abstract][Full Text] [Related]
4. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior.
Kiupel M; Webster JD; Bailey KL; Best S; DeLay J; Detrisac CJ; Fitzgerald SD; Gamble D; Ginn PE; Goldschmidt MH; Hendrick MJ; Howerth EW; Janovitz EB; Langohr I; Lenz SD; Lipscomb TP; Miller MA; Misdorp W; Moroff S; Mullaney TP; Neyens I; O'Toole D; Ramos-Vara J; Scase TJ; Schulman FY; Sledge D; Smedley RC; Smith K; W Snyder P; Southorn E; Stedman NL; Steficek BA; Stromberg PC; Valli VE; Weisbrode SE; Yager J; Heller J; Miller R
Vet Pathol; 2011 Jan; 48(1):147-55. PubMed ID: 21062911
[TBL] [Abstract][Full Text] [Related]
5. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study.
Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H
Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436
[TBL] [Abstract][Full Text] [Related]
6. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM
Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
[TBL] [Abstract][Full Text] [Related]
7. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification.
Śmiech A; Ślaska B; Łopuszyński W; Jasik A; Bochyńska D; Dąbrowski R
Acta Vet Scand; 2018 Nov; 60(1):70. PubMed ID: 30390687
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of exon 11 internal tandem duplications in the C-KIT proto-oncogene in Australian canine mast cell tumours.
Tamlin VS; Kessell AE; Mccoy RJ; Dobson EC; Smith TS; Hebart M; Brown L; Mitrovic D; Peaston AE
Aust Vet J; 2017 Oct; 95(10):386-391. PubMed ID: 28948627
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of pre-treatment biopsy for grading cutaneous mast cell tumours in dogs.
Shaw T; Kudnig ST; Firestone SM
Vet Comp Oncol; 2018 Jun; 16(2):214-219. PubMed ID: 28857446
[TBL] [Abstract][Full Text] [Related]
11. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment.
Welle MM; Bley CR; Howard J; Rüfenacht S
Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632
[TBL] [Abstract][Full Text] [Related]
12. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
13. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors.
Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH
Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564
[TBL] [Abstract][Full Text] [Related]
14. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
Giuliano A; Dos Santos Horta R; Constantino-Casas F; Hoather T; Dobson J
J Comp Pathol; 2017 Jan; 156(1):14-20. PubMed ID: 27889201
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases.
O'Connell K; Thomson M
Vet Comp Oncol; 2013 Mar; 11(1):51-62. PubMed ID: 22235766
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous mast cell tumour within a lipoma in a boxer.
Jakab C; Szász AM; Kulka J; Schaff Z; Rusvai M; Németh T; Gálfi P
Acta Vet Hung; 2009 Jun; 57(2):263-74. PubMed ID: 19584039
[TBL] [Abstract][Full Text] [Related]
17. Nanog Expression and Proliferation Indices in Canine Cutaneous Mast Cell Tumors.
Joselevitch JA; Barra CN; Vargas THM; Pulz LH; Nishiya AT; Kleeb SR; Xavier JG; Catão-Dias JL; Strefezzi RF
Vet Pathol; 2018 Nov; 55(6):849-852. PubMed ID: 30025495
[TBL] [Abstract][Full Text] [Related]
18. Grading Cutaneous Mast Cell Tumors in Cats.
Sabattini S; Bettini G
Vet Pathol; 2019 Jan; 56(1):43-49. PubMed ID: 30244666
[TBL] [Abstract][Full Text] [Related]
19. Concentration of extracellular vesicles isolated from blood relative to the clinical pathological status of dogs with mast cell tumours.
Šimundić M; Švara T; Štukelj R; Krek JL; Gombač M; Kralj-Iglič V; Tozon N
Vet Comp Oncol; 2019 Dec; 17(4):456-464. PubMed ID: 31066969
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours.
Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA
Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
